{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388844616577152.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/j.1365-2133.2005.06747.x"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2133.2005.06747.x"}},{"identifier":{"@type":"URI","@value":"http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2005.06747.x/fullpdf"}}],"dc:title":[{"@value":"Thalidomide: dermatological indications, mechanisms of action and side-effects"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380567183443376384","@type":"Researcher","foaf:name":[{"@value":"J.J. Wu"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844616577154","@type":"Researcher","foaf:name":[{"@value":"D.B. Huang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844616577156","@type":"Researcher","foaf:name":[{"@value":"K.R. Pang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844616577152","@type":"Researcher","foaf:name":[{"@value":"S. Hsu"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844616577153","@type":"Researcher","foaf:name":[{"@value":"S.K. Tyring"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00070963"},{"@type":"EISSN","@value":"13652133"}],"prism:publicationName":[{"@value":"British Journal of Dermatology"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2005-08","prism:volume":"153","prism:number":"2","prism:startingPage":"254","prism:endingPage":"273"},"reviewed":"false","dc:rights":["http://doi.wiley.com/10.1002/tdm_license_1.1"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2133.2005.06747.x"},{"@id":"http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2005.06747.x/fullpdf"}],"createdAt":"2005-07-28","modifiedAt":"2024-01-28","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360285708567021184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Self-disproportionation of enantiomers of thalidomide and its fluorinated analogue via gravity-driven achiral chromatography: mechanistic rationale and implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183443376384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Understanding the Thalidomide Chirality in Biological Processes by the Self-disproportionation of Enantiomers"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204142494208","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of Shelf-Stable Reagents for Fluoro-Functionalization Reactions"},{"@value":"Award Accounts : The Chemical Society of Japan Award for Creative Work for 2014 : Development of Shelf-Stable Reagents for Fluoro-Functionalization Reactions"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1365-2133.2005.06747.x"},{"@type":"CROSSREF","@value":"10.1039/c4sc03047h_references_DOI_FdziEmsPE3bYaMBm4SOWHpfS3lm"},{"@type":"CROSSREF","@value":"10.1038/s41598-018-35457-6_references_DOI_FdziEmsPE3bYaMBm4SOWHpfS3lm"},{"@type":"CROSSREF","@value":"10.1246/bcsj.20160223_references_DOI_FdziEmsPE3bYaMBm4SOWHpfS3lm"}]}